Tim Sharpington

Tim Sharpington is Chief Operating Officer of Microbiotica. He has established a track record of leading, developing, and executing company strategy, with experience in product development, fundraising, M&A, and licensing. He is responsible for developing strategy and development operations across the Company, managing Microbiotica’s product portfolio.

Tim brings over 30 years of experience in leadership roles in pharma, biotech, and CROs across Europe and the US. Prior companies include Vectura; Arakis, where Tim led the development of AD237 before its successful out license to Novartis; ICON and Sequus, where he led the development of DOXIL, an oncology product that was granted accelerated approval for ovarian cancer. His most recent role was COO of Open Orphan (formerly hVIVO) from 2018-to 2020.

Tim started his career as a postgraduate researcher at the London School of Hygiene and Tropical Medicine before working as Clinical Programme Manager at Pfizer. He has previously held Non-Executive Director positions at Ixico and Clinical Force.